• Study Resource
  • Explore Categories
    • Arts & Humanities
    • Business
    • Engineering & Technology
    • Foreign Language
    • History
    • Math
    • Science
    • Social Science

    Top subcategories

    • Advanced Math
    • Algebra
    • Basic Math
    • Calculus
    • Geometry
    • Linear Algebra
    • Pre-Algebra
    • Pre-Calculus
    • Statistics And Probability
    • Trigonometry
    • other →

    Top subcategories

    • Astronomy
    • Astrophysics
    • Biology
    • Chemistry
    • Earth Science
    • Environmental Science
    • Health Science
    • Physics
    • other →

    Top subcategories

    • Anthropology
    • Law
    • Political Science
    • Psychology
    • Sociology
    • other →

    Top subcategories

    • Accounting
    • Economics
    • Finance
    • Management
    • other →

    Top subcategories

    • Aerospace Engineering
    • Bioengineering
    • Chemical Engineering
    • Civil Engineering
    • Computer Science
    • Electrical Engineering
    • Industrial Engineering
    • Mechanical Engineering
    • Web Design
    • other →

    Top subcategories

    • Architecture
    • Communications
    • English
    • Gender Studies
    • Music
    • Performing Arts
    • Philosophy
    • Religious Studies
    • Writing
    • other →

    Top subcategories

    • Ancient History
    • European History
    • US History
    • World History
    • other →

    Top subcategories

    • Croatian
    • Czech
    • Finnish
    • Greek
    • Hindi
    • Japanese
    • Korean
    • Persian
    • Swedish
    • Turkish
    • other →
 
Profile Documents Logout
Upload
2015 Contributing editor Alexander Ehlers
2015 Contributing editor Alexander Ehlers

... regarding off-label use to health-care professionals allowed? ...
(lucinactant) Updated Product Specifications
(lucinactant) Updated Product Specifications

Prescription Drugs More Likely to Kill You than Recreational Drugs
Prescription Drugs More Likely to Kill You than Recreational Drugs

... What Makes Chantix So Dangerous? Chantix, which had the most adverse reaction reports of ANY medication currently on the market, works directly in your brain to ease nicotine withdrawal symptoms. The main ingredient in Chantix, varenicline, causes the release of dopamine within your brain while bloc ...
Public Assessment Report Scientific discussion Paroxetine Jubilant
Public Assessment Report Scientific discussion Paroxetine Jubilant

... conditions used in the stability studies are according to the ICH stability guideline. The product remains stable throughout the tested period, at long term and accelerated conditions. It has been demonstrated that the product insensitive to light exposure. Based on the results in the stability stud ...
ISHIK UNIVERSITY FACULTY OF DENTISTRY
ISHIK UNIVERSITY FACULTY OF DENTISTRY

...  Enteric coated tablets: The drugs which are destroyed by the gastric juices in the stomach, arecoated with keratin, shellac and cellulose acid phosphate. These substances are not dissolved by the acid juice of the stomach, but are dissolved in the intestinal juice (alkaline) only. ◦ Preventing gas ...
Revised: December 2016 AN: 00148/2016 SUMMARY OF
Revised: December 2016 AN: 00148/2016 SUMMARY OF

Physician Directed Use of Medical Products
Physician Directed Use of Medical Products

Mr.  Terry A.  Yimin CEO/President Essere Corporation Jormet Building
Mr. Terry A. Yimin CEO/President Essere Corporation Jormet Building

... stomach and gastrointestinal tract is also supported by the language of thei statutory sections immediatelypreceding and following section 35O(c)(l)(B)(ii). Sec$ion 350(c){ l)(B)(i) states:that the vitamin must be intended for ingestion in tablet, capsule or liquid form. Each of these forms denotesa ...
issa`s guide to the regulation of antibacterial hand soaps
issa`s guide to the regulation of antibacterial hand soaps

... In June of 1994, FDA issued a tentative monograph that applies to all antibacterial hand soaps. The tentative monograph contains most of the provisions that can be expected to be included in the final monograph, whenever it is issued. When the final monograph is published, companies involved with ha ...
MS fda workshop MRoessner
MS fda workshop MRoessner

... benefit and the side effect demonstrated that this [compound] was not as beneficial as Evista.’ … Douglas estimates that the … computer model … saved the company $50 million to $100 million, the cost of later-stage clinical trials. ‘We also avoided exposing a lot of women to a drug that ultimately w ...
http://www.fda.gov/downloads/AboutFD.../ucm095808.pdf
http://www.fda.gov/downloads/AboutFD.../ucm095808.pdf

... The "Guidelines on the WHO Certification Scheme on the Quality of Pharmaceutical Products moving in International Commerce" was revised in 1997. As a result, the Center for Drug Evaluation and Research (CDER) revised its procedures for the issuance of Certificates for Pharmaceutical Products to firm ...
Rodney Ferry testimony - Oregon Legislative Information System
Rodney Ferry testimony - Oregon Legislative Information System

... humans and animals. (2) The United States Food and Drug Administration and the Centers for Disease Control and Prevention have stated that there is a definitive link between the routine use of antibiotics for both disease prevention and growth promotion on industrial farms and the crisis of bacteria ...
Introduction to clinical trials
Introduction to clinical trials

... Pharmaceutical, diet, procedure, diagnostic, device, program, placebo. Subject from a target population. ...
HAZARD ANALYSIS
HAZARD ANALYSIS

... ...
Adverse Drug Events: A Perspective
Adverse Drug Events: A Perspective

project description - Standard drugs and drug standards
project description - Standard drugs and drug standards

... that we are becoming “neurochemical selves”2 as a starting point, I would like to write a history of personhood and of technologies of the self by writing a history of objects. Psychoactive drugs often become stabilized in a network of actors, bringing together different research areas and regimes o ...
Interferon-gamma (I3265) - Datasheet - Sigma
Interferon-gamma (I3265) - Datasheet - Sigma

drug master file: [18f]fdg
drug master file: [18f]fdg

... MD): 14 days at 30-35° C. ii. Soybean Casein Broth (BBL, Division of Becton-Dickinson Co., Cockeysville, MD): 14 days at 20-25° C. Positive growth is indicated by cloudiness in the culture media. Results will be compared to positive and negative controls. The efficacy of utilizing a 0.22 µm membrane ...
Radiopharmaceutical Details: 18F-FDG 1. Name
Radiopharmaceutical Details: 18F-FDG 1. Name

... MD): 14 days at 30-35° C. ii. Soybean Casein Broth (BBL, Division of Becton-Dickinson Co., Cockeysville, MD): 14 days at 20-25° C. Positive growth is indicated by cloudiness in the culture media. Results will be compared to positive and negative controls. The efficacy of utilizing a 0.22 µm membrane ...
ProArgi-9
ProArgi-9

... sleep on an empty stomach. Do not ingest food, including protein drinks, high glycemic drinks, or supplements containing any other amino acids with or within 2 hours of taking this product at bedtime. Ingesting food, amino acids, or high glycemic ingredients with or near this product is not in any w ...
Eleventh Specialty Pharma Newsletter (December 2009)
Eleventh Specialty Pharma Newsletter (December 2009)

... FDA Drug Safety Communication: Risk of next-morning impairment after use of insomnia drugs; FDA requires lower recommended doses for certain drugs containing zolpidem (Ambien, Ambien CR, Edluar, and Zolpimist). The U.S. Food and Drug Administration (FDA) is notifying the public of new information ab ...
A Marketing Authorisation Application (MAA) can be the same
A Marketing Authorisation Application (MAA) can be the same

... Harmonisation of the regulatory approval process for new medicines in Europe and the USA has advanced dramatically in recent years. Guidelines from both the European Medicines Agency (EMA) and the Food and Drug Administration (FDA) have been revised in line with these harmonisations. Despite this, T ...
Microdosing: safer clinical trials and fewer animal tests
Microdosing: safer clinical trials and fewer animal tests

... the rhesus monkey and human sequences. A microdose study with TGN1412, by systemic or dermal application, could have determined the amount of the antibody that bound to T cells in the whole human body without risk to the subjects, as well as providing pharmacokinetic and metabolic data relevant to t ...
IMMUNOMEDICS` UNLABELED CEA ANTIBODY INHIBITS HUMAN
IMMUNOMEDICS` UNLABELED CEA ANTIBODY INHIBITS HUMAN

... of cancer and infectious diseases. Integral to these products are highly specific monoclonal antibodies and antibody fragments designed to deliver radioisotopes and chemotherapeutic agents to tumors and sites of infection. Immunomedics has six therapeutic product candidates in clinical trials and ha ...
Slide headline - Sunstein Kann Murphy & Timbers LLP
Slide headline - Sunstein Kann Murphy & Timbers LLP

... Limited shelf life of ITU applications • Generally must commence use in approximately 4 years from application date • Can be problematic given the uncertainties involved in the drug development time frame ...
< 1 ... 166 167 168 169 170 171 172 173 174 ... 193 >

Biosimilar

A biosimilar (also known as follow-on biologic or subsequent entry biologic) is a biologic medical product which is a copy of an original product that is manufactured by a different company. Biosimilars are officially approved versions of original ""innovator"" products, and can be manufactured when the original product's patent expires. Reference to the innovator product is an integral component of the approval.Unlike the more common small-molecule drugs, biologics generally exhibit high molecular complexity, and may be quite sensitive to changes in manufacturing processes. Follow-on manufacturers do not have access to the originator's molecular clone and original cell bank, nor to the exact fermentation and purification process, nor to the active drug substance. They do have access to the commercialized innovator product.Drug related authorities such as European Medicines Agency (EMA), Food and Drug Administration (FDA), and Health Canada hold their own guidance on requirements for demonstration of the similar nature of two biological products in terms of safety and efficacy. According to them, analytical studies that demonstrate that the biological product is highly similar to the reference product notwithstanding minor differences in clinically inactive components; animal studies (including the assessment of toxicity); and a clinical study or studies (including the assessment of immunogenicity and pharmacokinetics or pharmacodynamics) that are sufficient to demonstrate safety, purity, and potency in one or more appropriate conditions of use for which the reference product is licensed and intended to be used and for which licensure is sought for the biological product.In case of a monoclonal antibody-containing medicinal product, such as Remsima, extensive physicochemical and biological characterization for it and its reference product Remicade was conducted in order to demonstrate their highly similar properties. Consequently, EMA have granted a marketing authorisation for only a few numbers of biosimilars since 2006 including a monoclonal antibody which is recently approved. Meanwhile, on March 6, 2015, the FDA approved the United States's first biosimilar product, the biosimilar filgrastim Zarxio.
  • studyres.com © 2025
  • DMCA
  • Privacy
  • Terms
  • Report